The increase in the average 12-month price target for HRMY by 31.9% to $38.25, along with the recent bullish analyst ratings, suggests a positive short-term impact on HRMY's stock price. The company's strong financial health, including a remarkable revenue growth rate and high net margin, further supports this outlook. The detailed analysis and updates from analysts at Needham, Mizuho, Goldman Sachs, and B of A Securities indicate a consensus towards a bullish perspective, making it likely that HRMY's stock price will experience upward movement in the short term.